FDA Drug Application (020401) for TIAZAC by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number020401
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage120MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB4 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTIAZAC
Active IngredientDILTIAZEM HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DILTIAZEM HYDROCHLORIDE11


Back to FDA Applications sponsored by VALEANT PHARMS NORTH